Group 1 - The eighth China International Import Expo (CIIE) is set to open, with Novartis participating for the eighth consecutive time, emphasizing its commitment to being a valuable and trustworthy healthcare partner in China [1][2] - Novartis will showcase nearly 20 innovative products across four core therapeutic areas: cardiovascular, renal and metabolic, oncology, and neuroscience, highlighting its strong innovation capabilities [1] - The "Focus on Innovation" exhibition area will feature award-winning products and immersive experiences, allowing attendees to engage with cutting-edge drug mechanisms and treatment methods [1] Group 2 - Novartis aims to deepen its roots in China, reflecting on its century-long history in the country and its new vision for development since 2018, which includes increased investment and collaboration with local industries [2] - The "Access to Medicine" exhibition area will demonstrate Novartis's efforts to enhance medicine accessibility for Chinese patients through partnerships with government, hospitals, and industry players [2] - A giant curved screen at the Novartis booth will showcase advanced pharmaceutical technologies, while an employer culture experience area will allow visitors to engage with the company's culture and receive commemorative badges [2]